Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS) - Fussner, Lynn A.; Flores-Suárez, Luis Felipe; Cartin-Ceba, Rodrigo; Specks, Ulrich; Cox, P. Gerard; Jayne, David R. W.; Merkel, Peter A.; Walsh, Michael; Paizis, Kathy; Walters, Giles; Jardine, Meg; Milton, Caroline; et al. (American journal of respiratory and critical care medicine, 2024)
Keywords: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy; Antibodies; Autoimmune diseases; Clinical outcomes; Female; Glucocorticoids - therapeutic use; Hemorrhage; Hemorrhage - etiology; Hemorrhage - therapy; Humans; Inflammatory diseases; Lung diseases; Lung Diseases - etiology; Lung Diseases - therapy; Male; Middle Aged; Original; Plasma Exchange - methods; Pulmonary Alveoli; Respiration, Artificial - statistics & numerical data; Side effects; Treatment Outcome; Vein & artery diseases; respiratory failure; glucocorticoids; diffuse alveolar hemorrhage; plasma exchange